Minimal residual resistance in CML: Stable BCR-ABL gene expression at levels 0.01-0.1% (IS) in the consecutive samples may be associated with BCR-ABL mutation development and MMoR lost in a small number of tyrosine kinase inhibitor responders.

• Authors: MACHOVÁ POLÁKOVÁ Kateřina; NÁDVORNÍKOVÁ Sylvie; ZEMANOVÁ Karla; KLAMOVÁ Hana; JURČEK Tomáš; DVOŘÁKOVÁ Dana; ŽÁČKOVÁ Daniela; MAYER Jiří; TRNĚNÝ Marek; MORAVCOVÁ Jana
• Year of publication: 2010
• Type: Conference abstract
• MU Faculty or unit: Faculty of Medicine

Related projects

• Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies